| Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. J Hu, C Seeger Proceedings of the National Academy of Sciences 93 (3), 1060-1064, 1996 | 431 | 1996 |
| Hepadnavirus assembly and reverse transcription require a multi‐component chaperone complex which is incorporated into nucleocapsids J Hu, DO Toft, C Seeger The EMBO journal, 1997 | 426 | 1997 |
| A global scientific strategy to cure hepatitis B PA Revill, FV Chisari, JM Block, M Dandri, AJ Gehring, H Guo, J Hu, ... The lancet Gastroenterology & hepatology 4 (7), 545-558, 2019 | 421 | 2019 |
| Complete and incomplete hepatitis B virus particles: formation, function, and application J Hu, K Liu Viruses 9 (3), 56, 2017 | 278 | 2017 |
| Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function J Hu, D Flores, D Toft, X Wang, D Nguyen Journal of virology 78 (23), 13122-13131, 2004 | 226 | 2004 |
| Formation of hepatitis B virus covalently closed circular DNA: removal of genome-linked protein W Gao, J Hu Journal of virology 81 (12), 6164-6174, 2007 | 220 | 2007 |
| Secretion of genome-free hepatitis B virus–single strand blocking model for virion morphogenesis of para-retrovirus X Ning, D Nguyen, L Mentzer, C Adams, H Lee, R Ashley, S Hafenstein, ... PLoS pathogens 7 (9), e1002255, 2011 | 207 | 2011 |
| Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G DH Nguyen, S Gummuluru, J Hu Journal of virology 81 (9), 4465-4472, 2007 | 204 | 2007 |
| Reverse transcription-associated dephosphorylation of hepadnavirus nucleocapsids DH Perlman, EA Berg, PB O'connor, CE Costello, J Hu Proceedings of the National Academy of Sciences 102 (25), 9020-9025, 2005 | 166 | 2005 |
| Hepadnavirus genome replication and persistence J Hu, C Seeger Cold Spring Harbor perspectives in medicine 5 (7), a021386, 2015 | 145 | 2015 |
| In vitro reconstitution of functional hepadnavirus reverse transcriptase with cellular chaperone proteins J Hu, D Toft, D Anselmo, X Wang Journal of virology 76 (1), 269-279, 2002 | 145 | 2002 |
| Evaluation of new antiviral agents: I. In vitro perspectives JM Hu, GD Hsiung Antiviral research 11 (5-6), 217-232, 1989 | 140 | 1989 |
| Revisiting hepatitis B virus: challenges of curative therapies J Hu, U Protzer, A Siddiqui Journal of virology 93 (20), 10.1128/jvi. 01032-19, 2019 | 131 | 2019 |
| Hepatitis B virus–cell interactions and pathogenesis DH Nguyen, L Ludgate, J Hu Journal of cellular physiology 216 (2), 289-294, 2008 | 126 | 2008 |
| Hepatitis B virus reverse transcriptase: diverse functions as classical and emerging targets for antiviral intervention SA Jones, J Hu Emerging microbes & infections 2 (1), 1-11, 2013 | 119 | 2013 |
| Regulation of hepadnavirus reverse transcription by dynamic nucleocapsid phosphorylation SH Basagoudanavar, DH Perlman, J Hu Journal of virology 81 (4), 1641-1649, 2007 | 114 | 2007 |
| In vitro reconstitution of a functional duck hepatitis B virus reverse transcriptase: posttranslational activation by Hsp90 J Hu, D Anselmo Journal of virology 74 (24), 11447-11455, 2000 | 114 | 2000 |
| Hepatitis B virus reverse transcriptase and å RNA sequences required for specific interaction in vitro J Hu, M Boyer Journal of virology 80 (5), 2141-2150, 2006 | 109 | 2006 |
| Cell and animal models for studying hepatitis B virus infection and drug development J Hu, YY Lin, PJ Chen, K Watashi, T Wakita Gastroenterology 156 (2), 338-354, 2019 | 100 | 2019 |
| Conditional replication of duck hepatitis B virus in hepatoma cells JT Guo, M Pryce, X Wang, MI Barrasa, J Hu, C Seeger Journal of virology 77 (3), 1885-1893, 2003 | 94 | 2003 |
Suryaram GummuluruBoston University School of MedicineVerified email at bu.edu
